Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 125.55B | 122.68B | 150.74B | 161.88B | 140.32B | 110.79B |
Gross Profit | 24.94B | 23.73B | 31.86B | 36.93B | 31.25B | 21.15B |
EBITDA | 8.54B | 10.03B | -10.12B | 19.27B | -2.89B | 9.02B |
Net Income | 865.00M | 37.00M | -21.29B | 2.27B | -12.12B | 2.04B |
Balance Sheet | ||||||
Total Assets | 160.10B | 162.70B | 172.92B | 162.74B | 156.14B | 139.45B |
Cash, Cash Equivalents and Short-Term Investments | 25.15B | 23.87B | 45.30B | 26.14B | 24.76B | 23.73B |
Total Debt | 74.46B | 74.84B | 89.58B | 70.35B | 58.54B | 57.86B |
Total Liabilities | 105.56B | 106.03B | 119.31B | 112.06B | 111.42B | 87.54B |
Stockholders Equity | 53.99B | 56.12B | 53.10B | 50.26B | 44.42B | 51.60B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -9.82B | -22.42B | -11.69B | -294.00M | -1.45B |
Operating Cash Flow | 0.00 | -493.00M | -12.96B | -4.86B | 5.11B | 2.07B |
Investing Cash Flow | 0.00 | -9.75B | -4.82B | -6.83B | -5.21B | -3.03B |
Financing Cash Flow | 0.00 | -11.93B | 35.42B | 12.05B | -218.00M | -3.47B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥3.16T | 18.57 | 1.96% | 4.80% | 34.02% | ||
73 Outperform | ¥92.35B | 24.07 | 2.51% | 5.02% | -21.81% | ||
71 Outperform | ¥173.95B | 11.87 | 1.18% | 15.24% | 35.69% | ||
71 Outperform | ¥81.07B | 13.90 | 3.01% | -3.24% | -29.08% | ||
61 Neutral | €25.87B | 685.40 | 0.05% | ― | -18.61% | ― | |
58 Neutral | ¥312.21B | 133.16 | 3.62% | 5.82% | -71.97% | ||
56 Neutral | $3.18B | 5.02 | -5.68% | 5.66% | 8.05% | -41.83% |